Victoria Ninon Olivia Niklas
CIK: 0002012250
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FBLG
FibroBiologics, Inc.
Director
Discretionary Trading P&L
Holdings
About Niklas Victoria Ninon Olivia
Niklas Victoria Ninon Olivia (SEC CIK 0002012250) files insider reports with the SEC as Director of FibroBiologics, Inc. (FBLG).
Signal8 holds 2 ownership filings by Niklas Victoria Ninon Olivia, all Form 4s, filed between Jun 12, 2025 and Jun 23, 2026. Those filings report 2 transactions, from Jun 12, 2025 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Niklas Victoria Ninon Olivia's filings is in HOUSTON,, TX.
Recent filings by Niklas Victoria Ninon Olivia
Other insiders filing for FibroBiologics, Inc. (FBLG)
- Khoja Hamid, Chief Scientific Officer
- Steinberg Leigh, Director
- Rubins Kathleen Hallisey, Director
- Hoffman Robert E., Director
- Cilento Richard C. Jr., Director
- Link Matthew, Director